UM/Sylvester Opens New Clinical Trial of Novel Combination Therapy in Lymphoma and Leukemia
06.30.2004
The University of Miami Sylvester Comprehensive Cancer Center has opened a phase I clinical trial of a novel combination therapy for patients with certain types of leukemia and lymphoma. “The idea of this trial is to use an antibody which has had some success in the treatment of these disorders, but to try and augment the effects of that antibody in combination with Interleukin-2,” said Joseph D. Rosenblatt, M.D., associate director, clinical and translational research, UM/Sylvester.
